Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade

Robert L. Jacobs, Geoffrey W. Rake, Donald C. Fournier, Robert J Chilton, William G. Culver, Charles H. Beckmann

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Anaphylaxis to known allergens occurred in two patients under treatment for hypertension with propranolol. The clinical course of both cases was similar. Bradycardia associated with an undetectable blood pressure, unusual severity, and sluggish response to treatment were major common factors in which blockade of the beta-adrenergic system may have had a role. Propranolol, a beta-adrenergic antagonist that acts competitively by blocking the adenylate cyclase receptor on efferent cells, is well recognized to cause increased airways resistance in some asthmatic and normal subjects. It is postulated that propranolol potentiated anaphylaxis in these patients by inhibition of adenylate cyclase, resulting in lowered intracellular cyclic AMP and a lowered threshold of mediator release. The bradycardia during profound hypotension is attributed to an unopposed cholinergic action caused by blunting of the normal endogenogy beta-adrenergic response by propranolol.

Original languageEnglish (US)
Pages (from-to)125-127
Number of pages3
JournalThe Journal of Allergy and Clinical Immunology
Volume68
Issue number2
DOIs
StatePublished - 1981

Fingerprint

Anaphylaxis
Propranolol
Adrenergic Agents
Bradycardia
Adenylyl Cyclases
Pharmaceutical Preparations
Airway Resistance
Adrenergic beta-Antagonists
Cyclic AMP
Hypotension
Allergens
Cholinergic Agents
Blood Pressure
Hypertension
Therapeutics

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Jacobs, R. L., Rake, G. W., Fournier, D. C., Chilton, R. J., Culver, W. G., & Beckmann, C. H. (1981). Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade. The Journal of Allergy and Clinical Immunology, 68(2), 125-127. https://doi.org/10.1016/0091-6749(81)90170-6

Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade. / Jacobs, Robert L.; Rake, Geoffrey W.; Fournier, Donald C.; Chilton, Robert J; Culver, William G.; Beckmann, Charles H.

In: The Journal of Allergy and Clinical Immunology, Vol. 68, No. 2, 1981, p. 125-127.

Research output: Contribution to journalArticle

Jacobs, RL, Rake, GW, Fournier, DC, Chilton, RJ, Culver, WG & Beckmann, CH 1981, 'Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade', The Journal of Allergy and Clinical Immunology, vol. 68, no. 2, pp. 125-127. https://doi.org/10.1016/0091-6749(81)90170-6
Jacobs, Robert L. ; Rake, Geoffrey W. ; Fournier, Donald C. ; Chilton, Robert J ; Culver, William G. ; Beckmann, Charles H. / Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade. In: The Journal of Allergy and Clinical Immunology. 1981 ; Vol. 68, No. 2. pp. 125-127.
@article{daf6e727fa634595bf56d857a5bf562f,
title = "Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade",
abstract = "Anaphylaxis to known allergens occurred in two patients under treatment for hypertension with propranolol. The clinical course of both cases was similar. Bradycardia associated with an undetectable blood pressure, unusual severity, and sluggish response to treatment were major common factors in which blockade of the beta-adrenergic system may have had a role. Propranolol, a beta-adrenergic antagonist that acts competitively by blocking the adenylate cyclase receptor on efferent cells, is well recognized to cause increased airways resistance in some asthmatic and normal subjects. It is postulated that propranolol potentiated anaphylaxis in these patients by inhibition of adenylate cyclase, resulting in lowered intracellular cyclic AMP and a lowered threshold of mediator release. The bradycardia during profound hypotension is attributed to an unopposed cholinergic action caused by blunting of the normal endogenogy beta-adrenergic response by propranolol.",
author = "Jacobs, {Robert L.} and Rake, {Geoffrey W.} and Fournier, {Donald C.} and Chilton, {Robert J} and Culver, {William G.} and Beckmann, {Charles H.}",
year = "1981",
doi = "10.1016/0091-6749(81)90170-6",
language = "English (US)",
volume = "68",
pages = "125--127",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade

AU - Jacobs, Robert L.

AU - Rake, Geoffrey W.

AU - Fournier, Donald C.

AU - Chilton, Robert J

AU - Culver, William G.

AU - Beckmann, Charles H.

PY - 1981

Y1 - 1981

N2 - Anaphylaxis to known allergens occurred in two patients under treatment for hypertension with propranolol. The clinical course of both cases was similar. Bradycardia associated with an undetectable blood pressure, unusual severity, and sluggish response to treatment were major common factors in which blockade of the beta-adrenergic system may have had a role. Propranolol, a beta-adrenergic antagonist that acts competitively by blocking the adenylate cyclase receptor on efferent cells, is well recognized to cause increased airways resistance in some asthmatic and normal subjects. It is postulated that propranolol potentiated anaphylaxis in these patients by inhibition of adenylate cyclase, resulting in lowered intracellular cyclic AMP and a lowered threshold of mediator release. The bradycardia during profound hypotension is attributed to an unopposed cholinergic action caused by blunting of the normal endogenogy beta-adrenergic response by propranolol.

AB - Anaphylaxis to known allergens occurred in two patients under treatment for hypertension with propranolol. The clinical course of both cases was similar. Bradycardia associated with an undetectable blood pressure, unusual severity, and sluggish response to treatment were major common factors in which blockade of the beta-adrenergic system may have had a role. Propranolol, a beta-adrenergic antagonist that acts competitively by blocking the adenylate cyclase receptor on efferent cells, is well recognized to cause increased airways resistance in some asthmatic and normal subjects. It is postulated that propranolol potentiated anaphylaxis in these patients by inhibition of adenylate cyclase, resulting in lowered intracellular cyclic AMP and a lowered threshold of mediator release. The bradycardia during profound hypotension is attributed to an unopposed cholinergic action caused by blunting of the normal endogenogy beta-adrenergic response by propranolol.

UR - http://www.scopus.com/inward/record.url?scp=0019486795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019486795&partnerID=8YFLogxK

U2 - 10.1016/0091-6749(81)90170-6

DO - 10.1016/0091-6749(81)90170-6

M3 - Article

C2 - 6114116

AN - SCOPUS:0019486795

VL - 68

SP - 125

EP - 127

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2

ER -